OS Therapies
OSTX
6 hedge funds and large institutions have $624K invested in OS Therapies in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.08% less ownership
Funds ownership: 0.77% → 0.69% (-0.08%)
16% less capital inflows, than outflows
Capital inflows: $191K | Capital outflows: $228K
25% less funds holding
Funds holding: 8 → 6 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
CM Management
Gulf Breeze,
Florida
|
+$176K |
| 2 |
BlackRock
New York
|
+$9.21K |
| 3 |
Morgan Stanley
New York
|
+$5.51K |
| 4 |
BP
BFC Planning
Cedar Rapids,
Iowa
|
+$533 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$89.7K |
| 2 |
Delta Investment Management
San Francisco,
California
|
-$50.6K |
| 3 |
HRT Financial
New York
|
-$49K |
| 4 |
Virtu Financial
New York
|
-$28K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$10.7K |
OSTX Hedge Fund Activity: Q4 2024 in Review
6 of the 7,628 institutional investors tracked by Wall St. Rank reported a position in OS Therapies (OSTX) for Q4 2024, worth a combined $624K — up 39% from $449K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of OSTX and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was CM Management, adding an estimated $176K. The largest seller was Millennium Management, cutting an estimated $89.7K.
- 6 institutional investors held OS Therapies (OSTX) as of Q4 2024, down from 8 in Q3 2024.
- Funds reported $624K of OS Therapies stock for Q4 2024, up 39% quarter-over-quarter.
- 2 funds opened new OS Therapies positions in Q4 2024 and 4 closed out, a net change of -2 holders.
- The largest OS Therapies buyer in Q4 2024 was CM Management, an estimated $176K added.
- The largest OS Therapies seller in Q4 2024 was Millennium Management, an estimated $89.7K sold.
Based on aggregated 13F filings for Q4 2024.